Beyond PSA90: Deep PSA response predicts outcomes in nonmetastatic CRPC
{{output}}
Objectives: To evaluate whether deeper prostate-specific antigen (PSA) decline adds prognostic information beyond the conventional 90% decline benchmark (PSA90) in nonmetastatic castration-resistant prostate cancer (nmCRPC). ... ...